SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

J Korean Med Sci. 2014;29(11):1572-6.

Prevention of venous thromboembolism in medical intensive care unit: a multicenter observational study in Korea.

, , , , , , , , , , , , , ,

제1저자 이진우 · 교신저자 유철규

소속 (12)
  1. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  2. Department of Pulmonology, The Catholic University of Korea School of Medicine, Seoul, Korea.
  3. Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea.
  4. Department of Internal Medicine, University of Dongguk College of Medicine, Dongguk University Ilsan Hospital, Goyang, Korea.
  5. Department of Internal Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.
  6. Department of Respiratory Medicine and Allergy, Soonchunhyang University School of Medicine, Seoul, Korea.
  7. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  8. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  9. Department of Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon, Korea.
  10. Department of Internal Medicine, College of Medicine, Wonkwang University, Iksan, Korea.
  11. Department of Internal Medicine, College of Medicine, Inha University, Incheon, Korea.
  12. Department of Internal Medicine, Hallym University College of Medicine, Seoul, Korea.

Abstract

Patients admitted to medical intensive care unit (MICU) are at increased risk for venous thromboembolism (VTE); and prophylaxis is recommended. However, the actual range and frequency of VTE prophylaxis administered to MICU patients are not well defined. Patients over 40 yr of age and expected MICU stay of more than 48 hr were eligible for this observational cohort study of 23 MICUs in Korea. Patients already on anticoagulation therapy or those requiring anticoagulation for reasons other than VTE were excluded. Among 830 patients, VTE prophylaxis was given to 560 (67.5%) patients. Among 560 patients, 323 (38.9%) received pharmacoprophylaxis, 318 (38.4%) received mechanical prophylaxis and 81 (9.8%) received both forms of prophylaxis. About 74% of patients in the pharmacoprophylaxis group received low molecular weight heparin and 53% of the patients in the mechanical prophylaxis group used intermittent pneumatic compression. Most of the patients (90%) had more than one risk factor for VTE and the most common risk factor was old age, followed by heart and respiratory failure. In this observational cohort study of 23 MICUs in Korea, 67.5% of patients received thromboprophylaxis. Further studies are needed to clarify the role and efficacy of VTE prophylaxis in Korean critically ill patients.

Keywords

Intensive Care UnitsMedical PatientsThromboprophylaxisVenous Thromboembolism

Figures

Fig. 1
Fig. 1 Selection of study population and reasons. VTE, venous thromboembolism.

그림 출처: PubMed Central 공개 논문 (PMC4234927)

Conflict of interest statement

The authors have no conflicts of interest to disclose.

그 밖의 정보
출판 형태
Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, Observational Study
저널
Journal of Korean medical science · eISSN 1598-6357
전자 출판
2014-11-04
MeSH
Adult · Age Factors · Aged · Cohort Studies · Female · Heart Failure / complications · Heparin, Low-Molecular-Weight / therapeutic use · Humans · Intensive Care Units* · Length of Stay · Male · Mechanical Thrombolysis · Middle Aged · Republic of Korea · Respiratory Insufficiency / complications · Retrospective Studies · Risk Factors · Tomography, X-Ray Computed · Venous Thromboembolism / complications / prevention & control / therapy
Substances
Heparin, Low-Molecular-Weight
참고문헌
24편